SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:liu-73744"
 

Sökning: id:"swepub:oai:DiVA.org:liu-73744" > Overexpression of G...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00002895naa a2200325 4500
001oai:DiVA.org:liu-73744
003SwePub
008120112s2011 | |||||||||||000 ||eng|
024a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-737442 URI
024a https://doi.org/10.5301/JBM.2011.85502 DOI
040 a (SwePub)liu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Shen, Yang-meiu Linköpings universitet,Hälsouniversitetet,Onkologi4 aut0 (Swepub:liu)yansh76
2451 0a Overexpression of GLUT1 in colorectal cancer is independently associated with poor prognosis
264 1b Wichtig Editore,c 2011
338 a print2 rdacarrier
520 a Background: To investigate the expression of glucose transporter 1 (GLUT1) in colorectal cancer (CRC) and its relationship to clinicopathological variables. Methods: The expression of GLUT1 in 163 primary tumors together with the corresponding normal mucosa, and 36 liver metastases was examined using real-time PCR. Results: The mean value of GLUT1 was higher in primary tumors (50.390 +/- 68.648) than in the corresponding normal mucosa (20.437 +/- 28.703, p less than 0.0001), while there was no significant difference in GLUT1 expression between CRC and liver metastasis (50.390 +/- 68.648 vs 52.277 +/- 52.482, p = 0.190). In CRCs, GLUT1 expression was higher in poorly differentiated than in well and moderately differentiated tumors (p = 0.022), and higher in stage III + IV than in stage I + II tumors (p = 0.035). The patients with high-expressed GLUT1 had a worse prognosis than those with low-expressed GLUT1 independently of gender, age, tumor site, stage and differentiation (p = 0.026, RR 2.737, 95% CI 1.126-6.651) in stage I-III CRCs. In liver metastasis, GLUT1 expression was higher in larger tumors than in smaller ones (p = 0.025). Conclusions: Overexpression of GLUT1 in stage I-III CRCs was independently associated with poor prognosis.
653 a GLUT1; Colorectal cancer; Prognosis; Real-time PCR
653 a MEDICINE
653 a MEDICIN
700a Arbman, Gunnaru Östergötlands Läns Landsting,Linköpings universitet,Kirurgi,Hälsouniversitetet,Kirurgiska kliniken i Östergötland4 aut0 (Swepub:liu)gunar63
700a Olsson, Birgitu Linköpings universitet,Onkologi,Hälsouniversitetet4 aut0 (Swepub:liu)birol93
700a Sun, Xiao-Fengu Östergötlands Läns Landsting,Linköpings universitet,Onkologi,Hälsouniversitetet,Onkologiska kliniken US4 aut0 (Swepub:liu)xiasu45
710a Linköpings universitetb Hälsouniversitetet4 org
773t International Journal of Biological Markersd : Wichtig Editoreg 26:3, s. 166-172q 26:3<166-172x 0393-6155x 1724-6008
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-73744
8564 8u https://doi.org/10.5301/JBM.2011.8550

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy